A wealthy, diverse, dynamic, multi-cultural and bilingual nation, Canada wields tremendous influence in biopharma markets given its’ position as the ninth largest biopharma drug market in the world with a relatively small population of 37.59 million people. In the...
Charlotte Eye Ear Nose & Throat Associates, P.A. (CEENTA) has been a Charlotte, North Carolina region premier eye, ear, nose and throat care provider for adults and pediatric patients for nearly 100 years. With the largest multi-specialty practice on the East...
Clinical research site expansion continues at a healthy rate as CenExel Clinical Research, Inc. (“CenExel”) acquires Research Centers of America (RCA), a Hollywood, Florida based clinical investigational site. This acquisition enables CenExcel to expand their “Centers...
The value-driven, precision-based drug development boom now underway introduces new complexity and competitive dynamics for drug development including clinical trials. Traditional small molecule-based biotech therapies focus on addressing symptoms of disease while...
Private-equity-infused clinical investigational sites continue to scour America and beyond for acquisitions—seeking scale, diverse therapeutic capability and patient access for CROs and biopharmaceutical sponsors. Now, Headlands Research, a KKR-backed next-generation...
Health providers, from small regional hospitals to major health systems, increasingly form alliances to facilitate and support participation in clinical trials. One prominent and recent example is the PIER Consortium™. An emerging trend known as clinical research as a...
